The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy

Line V Hjelle; Marie Sælen; Erling Aarsæther; Tore Knutsen; Sigve Andersen; Anne G Bentzen; Elin Richardsen; Tom Wilsgaard; Sophie D Fosså; Hege S Haugnes

doi:10.1016/j.euros.2023.04.005

The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy

Eur Urol Open Sci. 2023 May 13:53:6-15. doi: 10.1016/j.euros.2023.04.005. eCollection 2023 Jul.

Authors

Line V Hjelle¹, Marie Sælen¹, Erling Aarsæther², Tore Knutsen^{2

3}, Sigve Andersen^{1

3}, Anne G Bentzen¹, Elin Richardsen⁴, Tom Wilsgaard⁵, Sophie D Fosså⁶, Hege S Haugnes^{1

3}

Affiliations

¹ Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
² Department of Urology, University Hospital of North Norway, Tromsø, Norway.
³ Department of Clinical Medicine, UIT The Artic University, Tromsø, Norway.
⁴ Department of Pathology, University Hospital of North Norway, Tromsø, Norway.
⁵ Institute of Community Medicine, UIT-The Artic University, Tromsø, Norway.
⁶ Division of Cancer Medicine and Radiotherapy, Oslo University Hospital, Oslo, Norway.

Abstract

Background: Patient-reported outcome measures (PROMs) after prostate cancer (PC) treatment, including both radical prostatectomy (RP) and salvage radiation therapy (SRT), are under-reported.

Objective: To investigate PROMs longitudinally from before SRT until 18 mo after SRT for men treated with contemporary treatment modalities.

Design setting and participants: This prospective, longitudinal cohort study included 120 men (whole cohort) treated with SRT administered with volumetric modulated arc radiotherapy from 2016 to 2021 at the University Hospital of North Norway. The whole cohort was followed from before SRT until 18 mo after SRT. A subcohort of 48 men was followed from before RP until 18 mo after SRT.

Outcome measurements and statistical analysis: PROMs were collected with the Expanded Prostate Cancer Index-26 (EPIC-26), covering symptoms of urinary incontinence, urinary irritative, bowel, sexual, and hormonal domains. The domain scores were inquired before RP, 3 mo after RP, before SRT, at SRT termination, and 3 and 18 mo after SRT. We used linear mixed models with repeated measurements design to assess changes in PROMs throughout the treatment period.

Results and limitations: The median age before SRT was 63 yr. For the whole cohort, all five domains worsened at 3 and 18 mo after SRT compared with those before SRT. The estimated mean changes from before SRT to 18 mo after SRT are as follows: urinary incontinence -13.1, urinary irritative function -10.4, bowel -16.8, sexual function -9.1, and hormonal function -20.2 (at clinically important levels for all domains but sexual). For the subcohort, the mean urinary incontinence, bowel, sexual, and hormonal functions were significantly worsened 3 and 18 mo after SRT compared with those before RP at clinically important levels.

Conclusions: Men treated for PC report particular increased severity of urinary, bowel, sexual, and hormonal symptoms after SRT compared with baseline status.

Patient summary: For men with prostate cancer, the treatment combination of surgery and salvage radiotherapy worsens urinary incontinence and bowel, sexual, and hormonal functions.

Keywords: Adverse health outcomes; Expanded Prostate Cancer Index-26; Patient-reported outcome measures; Prostate cancer; Salvage radiation therapy.